Table 3.
Survival.
| 5-FU-Based CT Treatment N = 95 |
Capecitabine-Based CT Treatment N = 62 |
p-Value | |
|---|---|---|---|
| Follow-up median (months) CI95% | 67.44 (63.51; 78.03) | 41.51 (34.59; 46.26) | / |
| PFS rate (%) CI95% | 2 years: 82 (73; 88) 3 years: 80 (70; 87) |
2 years: 79 (67; 87) 3 years: 75 (62; 84) |
0.3170 |
| OS rate (%) CI95% | 2 years: 94 (86; 97) 3 years: 91 (83; 96) |
2 years: 95 (86; 98) 3 years: 86 (72; 93) |
0.2431 |
| CFS rate (%) CI95% | 2 years: 93 (86; 97) 3 years: 92 (85; 96) |
2 years: 85 (74; 92) 3 years: 85 (74; 92) |
0.1113 |
CFS = colostomy-free survival.